Wanlong H. Tan

17 Hongqi Avenue
Ganzhou, 341000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 110 publications

AARS2-mediated lactylation of ULK1 promotes autophagy-dependent progression of clear cell renal cell carcinoma.

AARS2-mediated lactylation of ULK1 promotes autophagy-dependent progression of clear cell renal cell carcinoma.

Journal: Autophagy

Published: July 01, 2026

H3K18la-PSMG1 Axis in Bladder Cancer Progression: Curcumin as a Therapeutic Candidate.

H3K18la-PSMG1 Axis in Bladder Cancer Progression: Curcumin as a Therapeutic Candidate.

Journal: International journal of biological sciences

Published: March 27, 2026

Shikonin inhibits bladder cancer progression by targeting deoxyribonuclease 2 to suppress reticulon 3-dependent endoplasmic reticulum autophagy.

Shikonin inhibits bladder cancer progression by targeting deoxyribonuclease 2 to suppress reticulon 3-dependent endoplasmic reticulum autophagy.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: March 19, 2026

Joint effects and dynamic trajectories of metabolic insulin resistance and systemic inflammation in the risk of renal cell carcinoma: a UK Biobank cohort analysis.

Joint effects and dynamic trajectories of metabolic insulin resistance and systemic inflammation in the risk of renal cell carcinoma: a UK Biobank cohort analysis.

Journal: World journal of urology

Published: March 04, 2026

Lactate-driven H3K18 lactylation promotes cisplatin resistance in bladder cancer via HNRNPF-Parkin mediated mitophagy.

Lactate-driven H3K18 lactylation promotes cisplatin resistance in bladder cancer via HNRNPF-Parkin mediated mitophagy.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: January 07, 2026

Multi-omics analysis and preliminary experimental validation of acetyl tributyl citrate (ATBC) promoting bladder cancer progression via the AKR1B1/EMT axis.

Multi-omics analysis and preliminary experimental validation of acetyl tributyl citrate (ATBC) promoting bladder cancer progression via the AKR1B1/EMT axis.

Journal: Environmental pollution (Barking, Essex : 1987)

Published: January 02, 2026

TMEM11 promotes cisplatin resistance by inhibiting BNIP3-mediated mitophagy in bladder cancer.

TMEM11 promotes cisplatin resistance by inhibiting BNIP3-mediated mitophagy in bladder cancer.

Journal: Cancer letters

Published: September 10, 2025

A case of retroperitoneal giant leiomyoma and literature review.

A case of retroperitoneal giant leiomyoma and literature review.

Journal: Therapeutic advances in urology

Published: August 25, 2025

MCUB Inhibits PRKN-Dependent Mitophagic Degradation of PD-L1 to Promote Immune Evasion in Bladder Cancer.

MCUB Inhibits PRKN-Dependent Mitophagic Degradation of PD-L1 to Promote Immune Evasion in Bladder Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 04, 2025

Developing and experimentally validating a glucocorticoid signaling-related gene signature to evaluate the prognosis and immunotherapeutic response in kidney renal clear cell carcinoma.

Developing and experimentally validating a glucocorticoid signaling-related gene signature to evaluate the prognosis and immunotherapeutic response in kidney renal clear cell carcinoma.

Journal: PloS one

Published: June 14, 2025

Methylparaben and propylparaben promote bladder cancer invasion via MMP2 and PPARG modulation.

Methylparaben and propylparaben promote bladder cancer invasion via MMP2 and PPARG modulation.

Journal: Ecotoxicology and environmental safety

Published: June 10, 2025

Deep learning-based segmentation and subtype prediction of renal cell carcinoma on contrast-enhanced CT.

Deep learning-based segmentation and subtype prediction of renal cell carcinoma on contrast-enhanced CT.

Journal: NPJ precision oncology

Published: April 19, 2025

Showing 1-12 of 110

Last Updated: 09/26/2026